Allergan Inc $165.62

down -0.24


1/8/2014 04:03 PM  |  NYSE : AGN  
Industries : Drugs / Drug Manufacturers - Other
Get Trend Analysis Icon Get AGN Trend Analysis - it has outperformed the S&P 500 by 69%

Partner Headlines

  1. Thursday's Selling Momentum Continues In To Friday

    Benzinga
  2. Thursday's Selling Momentum Continues Into Friday

    Benzinga
  3. US M&A Announced Deals Surpass $1 Trillion For 2014

    Benzinga
  4. Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan ...

    Benzinga
  5. Valeant Guides Outlook Low

    IBD
  6. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  7. Valeant Q2 Meets Views; Guidance Down On Asset Sale

    IBD
  8. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  9. George Soros Reveals His Largest Stake

    GuruFocus
  10. Earnings Season Boosts Confidence; S&P Trades At Record Highs

    Benzinga
  11. BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share

    Benzinga
  12. UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways

    Benzinga
  13. Allergan EPS Gains Accelerate

    IBD
  14. Allergan Earnings Growth, Job Cuts Counter Valeant

    IBD
  15. UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce

    Benzinga
  16. Allergan to Slash 13% of its Global Workforce

    FoxBusiness
  17. UPDATE: Valeant Complains to SEC Regarding Allergan Claims

    Benzinga
  18. Earnings Scheduled For July 21, 2014

    Benzinga
  19. Stocks To Watch For July 21, 2014

    Benzinga
  20. Pershing Square Releases Letter To Allergan's Board Of Directors, Fund ...

    Benzinga
  21. Valeant Submits HSR Filing Related to Proposed Allergan Deal

    Benzinga
  22. Allergan Issues Comment on Pershing's Definitive Proxy Statement

    Benzinga
  23. Apple And 4 Other Environmentally Responsible Companies

    Benzinga
  24. Benzinga's M&A Chatter for Wednesday July 9, 2014

    Benzinga
  25. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga
  26. Allergan

    IBD
  27. FDA Approves Allergan's Ozurdex, Rejects Levadex

    Benzinga
  28. Sterne Agee Feels More Positive On Allergan Following Recent Call With ...

    Benzinga
  29. Benzinga's Weekend M&A Chatter

    Benzinga
  30. Allergan

    IBD
  31. Stocks Mildly Higher To End The Week

    Benzinga
  32. Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest ...

    Benzinga
  33. Benzinga's M&A Chatter for Thursday June 26, 2014

    Benzinga
  34. Benzinga's M&A Chatter for Wednesday June 25, 2014

    Benzinga
  35. Paulson builds Allergan stake

    IBD
  36. Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson

    Benzinga
  37. Markets Close Higher Despite A Contraction In GDP

    Benzinga
  38. Benzinga's M&A Chatter for Tuesday June 24, 2014

    Benzinga
  39. Walgreen Falls On Weak Earnings, Alliance Boots Reset

    IBD
  40. Bulls Take A Break As Dow's Winning Streak Ends At 7 Days

    Benzinga
  41. 'Merger Monday' Deals, Offers And Rejections

    Benzinga
  42. Allergan Rebuffs Valeant's Tender Offer

    FoxBusiness
  43. Shire Rejects AbbVie's $46 Bil Tax-Inversion Attempt

    IBD
  44. Valeant launches hostile bid

    IBD
  45. M&A Activity Helps Fuel Healthy Action In Drugmakers

    IBD
  46. Benzinga's M&A Chatter for Wednesday June 18, 2014

    Benzinga
  47. Market Wrap For June 18: Markets Rally On Fed Comments And Tapering

    Benzinga
  48. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  49. Stocks Meander As Fed Announcement Looms

    IBD
  50. Air Products Soars As CEO Pick Suggests Asset Sales

    IBD
Trading Center